These researchers want to normalize menopause before treating symptoms with medicine.
Menopause is an inevitable part of life for half the world’s population. Almost one billion are currently postmenopausal.
In higher-income countries with more age and gender bias, menopause is treated as an endocrine deficiency and physicians will prescribe medication. For example, the neurokinin B receptor antagonist fezolinetant is effective in treating vasomotor symptoms like hot flashes. In other cultures, such as in Indigenous communities in Australia, aging is met with more respect and menopause is not as drastic of a change.
A global team of researchers led by Martha Hickey MBChB, M.D., a professor in the Department of Obstetrics, Gynecology and Newborn Health at The Royal Women’s Hospital in Melbourne, Australia, are suggesting alternate methods that focus on normalizing menopause.
The study was published online and is the first in a four-part series about menopause in The Lancet.
The team used information found via databases including MEDLINE, Embase, BioMed Central, Cochrane and Google from Dec. 2020, to July 2023 to find the most recent menopause treatment guidelines and their effectiveness.
“Many women navigate menopause without the need for medical intervention, but some experience symptoms that affect function and quality of life. Those seeking medical care are often looking for information rather than drug treatment unless their symptoms are severe,” the researchers write.
A woman is considered post-menopausal after 12 months without a menstrual period. There is also no universal menopausal syndrome, meaning that everyone experiences it differently. There are common symptoms though. The biggest complaints from women are about vasomotor symptoms like hot flashes with 60% to 80% experiencing them within 2 years of their final menstrual period. This is followed by vaginal dryness which 10% to 40% of women endure.
The team suggests a multifaceted approach to menopause empowerment. The keys are:
“Women need easy access to unbiased, accurate information in a form they can understand, created without industry influence and without any hidden agendas to sell a drug or service,” the researchers write. “Normalizing menopause and providing realistic and balanced information about the likely nature, severity, and duration of symptoms can be empowering for women and help them to make decisions about management.”
Study Reveals Patients Benefit More with Female Doctors — More Particularly Female Patients
April 30th 2024Understanding how physician sex contributes to these disparities is crucial as evidence on the impact of physician sex on clinical outcomes remains limited, especially around patient sex.
Read More
The proposed rule for the fiscal year (FY) 2025 Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System introduces strategies to improve the well-being of Medicare beneficiaries, including efforts to tackle social determinants of health, create more robust emergency readiness and enhance maternal healthcare.
Read More
The IRA’s Impact on Women in Medicare
April 2nd 2024In 2025, the out-of-pocket cap and other Part D related provisions in the Inflation Reduction Act are projected to save women in Medicare an average of 28% in out-of-pocket costs, according to a new analysis from the Office of the Assistant Secretary for Planning and Evaluation.
Read More
With aging populations, osteoporosis rates are set to increase, and researchers are looking for the next innovative drug to help prevent or manage the bone disease as there is currently no drug that completely does so effectively, according to a recent study published in Advanced Science.
Read More